Skip to Main Content

Paper Details

Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma.
Neurooncol Adv
5
2022
Author NameAffiliation
Otto RapalinoMassachusetts General Hospital
Otto RapalinoHarvard Medical School
Tracy T BatchelorHarvard Medical School
Tracy T BatchelorBrigham and Women's Hospital
Tracy T BatchelorHarvard Medical School
Tracy T BatchelorBrigham and Women's Hospital
  • 1 - 6

Datasets

Release 1.2